103 Toxicity and treatment related adverse events of Ipilimumab and Nivolumab use in Mesothelioma - a retrospective study

Lung Cancer 2026

View at publisher

Authors: Bettina Teruzzi, Pritha Roy, Huma Zahid, Mathilda Cominos

DOI: 10.1016/j.lungcan.2026.109052

Cited by: 0

Fields of Study & Subjects

Occupational and environmental lung diseases Cancer Immunotherapy and Biomarkers Pharmacovigilance and Adverse Drug Reactions